Prognosis of asymptomatic coronary artery disease after percutaneous coronary intervention

Kohei Wakabayashi1, Cedric Delhaye, Gabriel Maluenda

  • 1Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, Washington, District of Columbia, USA.

Insights

Asymptomatic patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) had higher mortality rates. This study found that lack of symptoms was a predictor of increased 1-year mortality after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes

Background:

  • Treatment for asymptomatic obstructive coronary stenoses remains controversial.
  • The prognostic impact of percutaneous coronary intervention (PCI) in asymptomatic patients is not well-established.

Purpose of the Study:

  • To compare 1-year outcomes in stable coronary artery disease (CAD) patients who underwent elective PCI, stratified by symptom status (asymptomatic vs. symptomatic).

Main Methods:

  • A cohort of 1,944 consecutive stable CAD patients undergoing elective PCI were divided into asymptomatic (n=1,052) and symptomatic (n=892) groups.
  • One-year follow-up assessed all-cause mortality, nonfatal myocardial infarction, and target vessel revascularization.

Main Results:

  • Asymptomatic patients were older, more likely male, and had more comorbidities (renal insufficiency, prior MI, CABG) and lower ejection fraction.
  • The 1-year mortality rate was significantly higher in asymptomatic patients (4.1% vs. 1.8%, p=0.003).
  • Nonfatal myocardial infarction and target vessel revascularization rates were similar between groups.

Conclusions:

  • In stable CAD patients undergoing elective PCI, the absence of symptoms independently predicted increased 1-year mortality.
  • These findings challenge the assumption that asymptomatic status portends a better prognosis after PCI.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...